{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:15:09Z","timestamp":1740147309877,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Open Access Publication Fund of the University of Wuerzburg"},{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Severe acute respiratory syndrome coronavirus 2 is a virus affecting different organs and causing a wide variety and severity of symptoms. Headache as well as loss of smell and taste are the most frequently reported neurological manifestations of coronavirus disease 2019 induced by severe acute respiratory syndrome coronavirus 2. Here we report on a patient with chronic migraine and medication overuse headache, who experienced remarkable mitigation of migraine following coronavirus disease 2019.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>For many years prior to the severe acute respiratory syndrome coronavirus 2 infection, a 57-year-old Caucasian male suffered from very frequent migraine attacks and for control of headaches he had been taking triptans almost daily. In the 16-month period before the outbreak of coronavirus disease 2019, triptan was taken 98% of the days with only a 21-day prednisolone-supported triptan holiday, which, however, had no longer-lasting consequences on migraine frequency. Upon severe acute respiratory syndrome coronavirus 2 infection, the patient developed only mild symptoms including fever, fatigue, and headache. Directly following recovery from coronavirus disease 2019, the patient surprisingly experienced a period with largely reduced frequency and severity of migraine attacks. Indeed, during 80\u00a0days following coronavirus disease 2019, migraine as well as triptan usage were restricted to only 25% of the days, no longer fulfilling criteria of a chronic migraine and medication overuse headache.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Severe acute respiratory syndrome coronavirus 2 infection might be capable of triggering mitigation of migraine.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-023-03795-3","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T01:02:41Z","timestamp":1677027761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reduced frequency of migraine attacks following coronavirus disease 2019: a case report"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4538-2324","authenticated-orcid":false,"given":"Roland","family":"Houben","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"issue":"8","key":"3795_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","volume":"17","author":"AK Eigenbrodt","year":"2021","unstructured":"Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, et\u00a0al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021;17(8):501\u201314. https:\/\/doi.org\/10.1038\/s41582-021-00509-5.","journal-title":"Nat Rev Neurol"},{"issue":"34","key":"3795_CR2","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.2174\/0929867325666180719120215","volume":"26","author":"I Rainero","year":"2019","unstructured":"Rainero I, Vacca A, Govone F, Gai A, Pinessi L, Rubino E. Migraine: genetic variants and clinical phenotypes. Curr Med Chem. 2019;26(34):6207\u201321. https:\/\/doi.org\/10.2174\/0929867325666180719120215.","journal-title":"Curr Med Chem"},{"issue":"6","key":"3795_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s1098-3597(99)90036-4","volume":"1","author":"RE Ryan Jr","year":"1999","unstructured":"Ryan RE Jr. Headache diagnosis. Clin Cornerstone. 1999;1(6):11\u201320. https:\/\/doi.org\/10.1016\/s1098-3597(99)90036-4.","journal-title":"Clin Cornerstone"},{"issue":"28","key":"3795_CR4","doi-asserted-by":"publisher","first-page":"904","DOI":"10.15585\/mmwr.mm6928a2","volume":"69","author":"RM Burke","year":"2020","unstructured":"Burke RM, Killerby ME, Newton S, Ashworth CE, Berns AL, Brennan S, et\u00a0al. Symptom profiles of a convenience sample of patients with COVID-19\u2014United States, January-April 2020. MMWR Morb Mortal Wkly Rep. 2020;69(28):904\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm6928a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1\u20132","key":"3795_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neurol.2020.10.001","volume":"177","author":"A Maury","year":"2021","unstructured":"Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: a narrative review for clinicians. Rev Neurol (Paris). 2021;177(1\u20132):51\u201364. https:\/\/doi.org\/10.1016\/j.neurol.2020.10.001.","journal-title":"Rev Neurol (Paris)"},{"key":"3795_CR6","doi-asserted-by":"publisher","first-page":"627723","DOI":"10.3389\/fmolb.2021.627723","volume":"8","author":"P Borah","year":"2021","unstructured":"Borah P, Deb PK, Chandrasekaran B, Goyal M, Bansal M, Hussain S, et\u00a0al. Neurological consequences of SARS-CoV-2 infection and concurrence of treatment-induced neuropsychiatric adverse events in COVID-19 patients: navigating the uncharted. Front Mol Biosci. 2021;8:627723. https:\/\/doi.org\/10.3389\/fmolb.2021.627723.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"3795_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41232-021-00165-8","volume":"41","author":"Y Kase","year":"2021","unstructured":"Kase Y, Okano H. Neurological pathogenesis of SARS-CoV-2 (COVID-19): from virological features to clinical symptoms. Inflamm Regen. 2021;41(1):15. https:\/\/doi.org\/10.1186\/s41232-021-00165-8.","journal-title":"Inflamm Regen"},{"issue":"1","key":"3795_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s10194-021-01314-7","volume":"22","author":"JY Al-Hashel","year":"2021","unstructured":"Al-Hashel JY, Abokalawa F, Alenzi M, Alroughani R, Ahmed SF. Coronavirus disease-19 and headache; impact on pre-existing and characteristics of de novo: a cross-sectional study. J Headache Pain. 2021;22(1):97. https:\/\/doi.org\/10.1186\/s10194-021-01314-7.","journal-title":"J Headache Pain"},{"issue":"7","key":"3795_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1177\/0333102420981739","volume":"41","author":"IE Verhagen","year":"2021","unstructured":"Verhagen IE, van Casteren DS, de Vries LS, Terwindt GM. Effect of lockdown during COVID-19 on migraine: a longitudinal cohort study. Cephalalgia. 2021;41(7):865\u201370. https:\/\/doi.org\/10.1177\/0333102420981739.","journal-title":"Cephalalgia"},{"issue":"9","key":"3795_CR10","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1093\/pm\/pnaa449","volume":"22","author":"A Gonzalez-Martinez","year":"2021","unstructured":"Gonzalez-Martinez A, Planchuelo-G\u00f3mez \u00c1, Guerrero \u00c1L, Garc\u00eda-Azor\u00edn D, Santos-Lasaosa S, Navarro-P\u00e9rez MP, et\u00a0al. Evaluation of the impact of the COVID-19 lockdown in the clinical course of migraine. Pain Med. 2021;22(9):2079\u201391. https:\/\/doi.org\/10.1093\/pm\/pnaa449.","journal-title":"Pain Med"},{"issue":"5 Suppl 3","key":"3795_CR11","first-page":"S13","volume":"44","author":"B Baumel","year":"1994","unstructured":"Baumel B. Migraine: a pharmacologic review with newer options and delivery modalities. Neurology. 1994;44(5 Suppl 3):S13\u20137.","journal-title":"Neurology"},{"issue":"6","key":"3795_CR12","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1468-2982.2006.01172.x","volume":"26","author":"J Olesen","year":"2006","unstructured":"Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, et\u00a0al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;26(6):742\u20136. https:\/\/doi.org\/10.1111\/j.1468-2982.2006.01172.x.","journal-title":"Cephalalgia"},{"issue":"22","key":"3795_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3238\/arztebl.2018.0365","volume":"115","author":"HC Diener","year":"2018","unstructured":"Diener HC, Holle D, Dresler T, Gaul C. Chronic headache due to overuse of analgesics and anti-migraine agents. Dtsch Arztebl Int. 2018;115(22):365\u201370. https:\/\/doi.org\/10.3238\/arztebl.2018.0365.","journal-title":"Dtsch Arztebl Int"},{"issue":"10","key":"3795_CR14","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/j.1526-4610.2012.02223.x","volume":"52","author":"DC Buse","year":"2012","unstructured":"Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, et\u00a0al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(10):1456\u201370. https:\/\/doi.org\/10.1111\/j.1526-4610.2012.02223.x.","journal-title":"Headache"},{"issue":"4","key":"3795_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00415-016-8031-5","volume":"263","author":"YW Woldeamanuel","year":"2016","unstructured":"Woldeamanuel YW, Cowan RP. The impact of regular lifestyle behavior in migraine: a prevalence case-referent study. J Neurol. 2016;263(4):669\u201376. https:\/\/doi.org\/10.1007\/s00415-016-8031-5.","journal-title":"J Neurol"},{"issue":"1","key":"3795_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10194-020-01183-6","volume":"21","author":"JY Al-Hashel","year":"2020","unstructured":"Al-Hashel JY, Ismail II. Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study. J Headache Pain. 2020;21(1):115. https:\/\/doi.org\/10.1186\/s10194-020-01183-6.","journal-title":"J Headache Pain"},{"key":"3795_CR17","doi-asserted-by":"publisher","first-page":"678472","DOI":"10.3389\/fnhum.2021.678472","volume":"15","author":"C Fernandez-de-Las-Penas","year":"2021","unstructured":"Fernandez-de-Las-Penas C, Gomez-Mayordomo V, Garcia-Azorin D, Palacios-Cena D, Florencio LL, Guerrero AL, et\u00a0al. Previous history of migraine is associated with fatigue, but not headache, as long-term post-COVID symptom after severe acute respiratory SARS-CoV-2 infection: a case-control study. Front Hum Neurosci. 2021;15:678472. https:\/\/doi.org\/10.3389\/fnhum.2021.678472.","journal-title":"Front Hum Neurosci"},{"issue":"10","key":"3795_CR18","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1111\/head.13964","volume":"60","author":"B Martins","year":"2020","unstructured":"Martins B, Costa A. Migraine improvement during COVID-19 pandemic\u2014a case report on the wonders of a mask. Headache. 2020;60(10):2608\u20139. https:\/\/doi.org\/10.1111\/head.13964.","journal-title":"Headache"},{"issue":"7","key":"3795_CR19","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jiph.2021.04.013","volume":"14","author":"M Waliszewska-Prosol","year":"2021","unstructured":"Waliszewska-Prosol M, Budrewicz S. The unusual course of a migraine attack during COVID-19 infection\u2014case studies of three patients. J Infect Public Health. 2021;14(7):903\u20135. https:\/\/doi.org\/10.1016\/j.jiph.2021.04.013.","journal-title":"J Infect Public Health"},{"issue":"8","key":"3795_CR20","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1111\/head.13941","volume":"60","author":"PA Sampaio Rocha-Filho","year":"2020","unstructured":"Sampaio Rocha-Filho PA, Voss L. Persistent headache and persistent anosmia associated with COVID-19. Headache. 2020;60(8):1797\u20139. https:\/\/doi.org\/10.1111\/head.13941.","journal-title":"Headache"},{"key":"3795_CR21","doi-asserted-by":"publisher","first-page":"573421","DOI":"10.3389\/fneur.2020.573421","volume":"11","author":"H Yu","year":"2020","unstructured":"Yu H, Sun T, Feng J. Complications and pathophysiology of COVID-19 in the nervous system. Front Neurol. 2020;11:573421. https:\/\/doi.org\/10.3389\/fneur.2020.573421.","journal-title":"Front Neurol"},{"issue":"13","key":"3795_CR22","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1177\/0333102418771350","volume":"39","author":"D Levy","year":"2019","unstructured":"Levy D, Labastida-Ramirez A, MaassenVanDenBrink A. Current understanding of meningeal and cerebral vascular function underlying migraine headache. Cephalalgia. 2019;39(13):1606\u201322. https:\/\/doi.org\/10.1177\/0333102418771350.","journal-title":"Cephalalgia"},{"issue":"4","key":"3795_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/head.13053","volume":"57","author":"HG Sutherland","year":"2017","unstructured":"Sutherland HG, Griffiths LR. Genetics of migraine: insights into the molecular basis of migraine disorders. Headache. 2017;57(4):537\u201369. https:\/\/doi.org\/10.1111\/head.13053.","journal-title":"Headache"},{"key":"3795_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fncel.2014.00302","volume":"8","author":"MF DosSantos","year":"2014","unstructured":"DosSantos MF, Holanda-Afonso RC, Lima RL, DaSilva AF, Moura-Neto V. The role of the blood-brain barrier in the development and treatment of migraine and other pain disorders. Front Cell Neurosci. 2014;8:302. https:\/\/doi.org\/10.3389\/fncel.2014.00302.","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"3795_CR25","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.stem.2020.10.001","volume":"27","author":"L Pellegrini","year":"2020","unstructured":"Pellegrini L, Albecka A, Mallery DL, Kellner MJ, Paul D, Carter AP, et\u00a0al. SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids. Cell Stem Cell. 2020;27(6):951-61.e5. https:\/\/doi.org\/10.1016\/j.stem.2020.10.001.","journal-title":"Cell Stem Cell"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-03795-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-03795-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-03795-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T01:03:01Z","timestamp":1677027781000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-03795-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3795"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-03795-3","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2023,2,22]]},"assertion":[{"value":"9 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable because the author is reporting on himself.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The author declares no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}